Main Article Content
On November 1, 2019, POSNA published the inaugural edition of JPOSNA®. Over the last 4 years, our journal has grown in content and importance. We started as a journal exclusively focused on educational content, such as Current Concept Reviews and Surgical Techniques. Two years ago, under the leadership of Deputy Editor JR Cruz, we started accepting, adjudicating, and publishing Original Research. The number of these submissions has risen at a very high rate, and the quality is excellent. Our journal has been a fantastic resource for practicing pediatric orthopaedists, residents, and fellows. In addition to providing a location for publishing great content, our journal was an important revenue stream for our society when the pandemic reduced income from POSNA meetings.
The success of JPOSNA® is a POSNA success story. Your passion for educating, performing research, and advancing orthopaedic care for children is YOUR SUCCESS.
Recently, POSNA leadership formed a partnership with Elsevier. Together, we will continue to produce the same high-quality content you have come to expect from this journal. Elsevier’s staff and publishing platform will take JPOSNA® to the next level, where we will have a more global impact and where our research will be easily discovered and read through indexing databases.
We must recognize and thank our current Associate Editors for their outstanding work to date and appreciate their continued service in the future. We stand in awe and in the shadow of the foundational contribution of Bryan Tompkins who created the original JPOSNA® platform, spending only a few hundred dollars on software. Finally, we thank the POSNA staff, especially Executive Director Teri Stech and Managing Editor Lisa Dushane (who seems to answer emails at all hours of the day). It’s quite remarkable what they have done to facilitate our journal’s rise.
The following are answers to concerns/questions that we anticipate many of you may have in this time of transition.
- No changes to journal ownership or editorial policies
Elsevier will provide production, sales, and marketing services for JPOSNA® journals. While this partnership will add considerable resources and expertise to the JPOSNA® publications program, it will not impact ownership or control over decisions impacting JPOSNA®. We will continue to set policies that govern access to content and editorial appointments, for example. Similarly, the partnership will not impact editorial policies or publication decision criteria, which remain the sole purview of journal editors.
- Information for authors and reviewers
- At the current moment, we ask authors to hold new submissions to the current JPOSNA® website until the Editorial Manager submission site is available sometime before the end of 2023.
- Will the submission site change?
A new submission site will be created in Editorial Manager (EM) for JPOSNA®, and the details of this will be shared with you as soon as they are ready.
- Will the Elsevier agreement affect readership and citations of my article?
Through posting of JPOSNA® content on ScienceDirect, we expect exposure to your content to grow. In addition, with the help of a new generation of Elsevier platforms and analytical solutions, we expect JPOSNA® content to be discoverable to an even broader pool of researchers and health professionals. Under Elsevier’s open access agreements with countries and institutions, authors from well over 30 organizations will have the opportunity to publish under open access licenses via publish and read funding agreements. Finally, in partnership with Elsevier, JPOSNA® plans to transform into a fully open access journal as of 2024.
It is with great excitement that we start a new chapter in the history of JPOSNA® and our mission to improve musculoskeletal health in children. I think we can expect great things as we walk this journey together.